Thomas G. Ricks

Companies

• Faeth Therapeutics, Inc.Board member Feb 3, 2021 to now¹
• OvintivBoard member Feb 24, 2020 to now²
• EncanaBoard member Feb 22, 2019 to Nov 1, 2019³
• Newfield ExplorationBoard member May 17, 2006 to Feb 14, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Ovintiv OVV196,511 shares⁵$12.9M at $65.75May 21, 2026
• FTFaeth Therapeutics, Inc. FTH343,863 shares⁶$6.7M at $19.52Jul 12, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Exercised options 3,510 shares of Ovintiv⁵
• Dec 5, 2025Gift 900 shares of Ovintiv⁷
• Dec 5, 2025Gift 900 shares of Ovintiv⁷
• Dec 5, 2025Gift 900 shares of Ovintiv⁷
• Dec 5, 2025Gift 900 shares of Ovintiv⁷
• May 16, 2025Exercised options 5,501 shares of Ovintiv⁸
• May 17, 2024Exercised options 4,213 shares of Ovintiv⁹
• Mar 8, 2024Exercised options 8,402 shares of Ovintiv¹⁰
• Jul 10, 2023Granted 4,466 shares of Faeth Therapeutics, Inc.⁶
• May 18, 2023Exercised options 6,074 shares of Ovintiv¹¹
• Mar 8, 2023Exercised options 14,709 shares of Ovintiv¹²
• Oct 12, 2022Gift 10,000 shares of Ovintiv¹³
• Oct 12, 2022Gift 10,000 shares of Ovintiv¹³
• Jun 10, 2022Granted 4,466 shares of Faeth Therapeutics, Inc.¹⁴
• Jun 7, 2022Sold 19,231 shares at $59.50 of Ovintiv¹⁵
• May 23, 2022Sold 10,000 shares at $50.00 of Ovintiv¹⁶
• May 18, 2022Exercised options 4,499 shares of Ovintiv¹⁷
• Apr 18, 2022Sold 10,000 shares at $53.73 of Ovintiv¹⁸
• Mar 31, 2022Bought 19 shares of Ovintiv¹⁹
• Mar 8, 2022Exercised options 5,184 shares of Ovintiv²⁰
• Dec 10, 2021Bought 20,000 shares at $5.86 of Faeth Therapeutics, Inc.²¹
• Dec 9, 2021Bought 20,000 shares at $6.62 of Faeth Therapeutics, Inc.²¹